paclitaxel has been researched along with Leukemia, Lymphocytic, T Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, L; Panyam, J; Patil, Y; Sadhukha, T | 1 |
| Aliautdin, RN; Balaban'ian, VIu; Boiat, V | 1 |
| Blackinton, D; Klostergaard, J; Kouttab, N; Maizel, A; Mehta, S; Myrick, D; Wanebo, H | 1 |
3 other study(ies) available for paclitaxel and Leukemia, Lymphocytic, T Cell
| Article | Year |
|---|---|
Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotin; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Combinations; Drug Resistance, Neoplasm; Female; Humans; Lactic Acid; Leukemia, T-Cell; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasm Transplantation; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quinolines | 2009 |
[Intracellular accumulation and antitumor activity of various nanosomal formulations of paclitaxel].
Topics: Antineoplastic Agents, Phytogenic; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Jurkat Cells; Leukemia, T-Cell; Nanoparticles; Paclitaxel | 2011 |
Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Division; Ceramides; Drug Synergism; Humans; In Situ Nick-End Labeling; Jurkat Cells; Leukemia, T-Cell; Paclitaxel | 1999 |